Medical Condition News

RSS

ESCEO and IOF honor Dr. Mary L. Bouxsein with ESCEO-IOF Herbert Fleisch Medal

Dr. Mary L. Bouxsein has been awarded the ESCEO-IOF Herbert Fleisch Medal in honor of her work in the field of skeletal fragility.

18 Apr 2013

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.

18 Apr 2013

Telemedicine house calls for Parkinson’s patients: an interview with Dr Ray Dorsey, Johns Hopkins University

Access to neurological care for Parkinson disease is currently limited by distance, disability, and the distribution of doctors.

18 Apr 2013

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).

18 Apr 2013

Eli Lilly reports positive results from Phase III AWARD trials of type 2 diabetes drug, dulaglutide

Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.

18 Apr 2013

Mast Therapeutics' data show that MST-188 reduces aggregation of both older and younger RBC

Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.

18 Apr 2013

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

Scientists from academic institutions reported at the 2013 annual American Association for Cancer Research meeting, results from preclinical studies which showed that certain bladder cancers and mesotheliomas have metabolic changes and are more likely to respond to treatment with ADI-PEG 20 (pegylated arginine deiminase) if they are deficient in the enzyme, argininosuccinate synthetase.

18 Apr 2013

UTHealth neuroscientists demonstrate new strategy to overcome memory deficits

Neuroscientists at The University of Texas Health Science Center at Houston have taken a major step in their efforts to help people with memory loss tied to brain disorders such as Alzheimer's disease.

18 Apr 2013

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

The Korea-based international pharmaceutical company, SK Biopharmaceuticals, announced today the U.S. Food and Drug Administration has authorized the Investigational New Drug application for SKL15508 to treat cognitive impairment associated with schizophrenia.

18 Apr 2013

Study: Patients who suffer STEMI heart attacks while hospitalized are 10 times more likely to die

If you suffer a heart attack while walking down the street and are taken to the hospital quickly, your chances of survival are very good. But if you have a heart attack while already in the hospital for something else, you are 10 times more likely to die.

18 Apr 2013

Americans with brain diseases have more difficulty in finding a neurologist, new study reveals

Americans with brain diseases such as Alzheimer's disease, Parkinson's disease or multiple sclerosis who need to see a neurologist may face longer wait times or have more difficulty finding a neurologist, according to a new study published in the April 17, 2013, online issue of Neurology-, the medical journal of the American Academy of Neurology.

18 Apr 2013

European Congress on Osteoporosis & Osteoarthritis starts in Rome

The world's largest congress dedicated to the epidemiology, pathogenesis, prevention, and treatment of osteoporosis and osteoarthritis has opened today in Rome, Italy with 4500 delegates.

18 Apr 2013

State roundup: Immigration proposal could mean big state health care costs

Making immigrants ineligible for public health benefits -- at least initially -- under proposed immigration law changes would push the costs of health care from the federal government to states and counties, said Sonal Ambegaokar, a health policy attorney at the National Immigration Law Center.

18 Apr 2013

UTMB researchers identify protein that can interfere with the brain's response to leptin

Ever since the appetite-regulation hormone called leptin was discovered in 1994, scientists have sought to understand the mechanisms that control its action. It was known that leptin was made by fat cells, reduced appetite and interacted with insulin , but the precise molecular details of its function -details that might enable the creation of a new treatment for obesity - remained elusive.

18 Apr 2013

Scorecard compares how countries within EU care for people with osteoporosis

Today a panel of international experts working in cooperation with the International Osteoporosis Foundation have published SCOPE - or Scorecard for Osteoporosis in Europe.

18 Apr 2013

More culturally relevant cancer prevention education needed for minority populations

Researchers at Moffitt Cancer Center and colleagues analyzed national data to investigate the differences in cancer prevention beliefs by race and ethnicity. They found that minorities, including blacks, Asians and Hispanics, have differing beliefs about cancer prevention and feel they are less likely to get cancer than did whites.

18 Apr 2013

New pre-clinical study suggests novel drug combination therapy for leukemia treatment

A new, pre-clinical study by researchers at Virginia Commonwealth University Massey Cancer Center suggests that a novel drug combination could lead to profound leukemia cell death by disrupting the function of two major pro-survival proteins.

18 Apr 2013

Researchers find potential new genetic chemotherapy approach for cancer treatment

Researchers at The Jackson Laboratory have identified a molecule that prevents repair of some cancer cells, providing a potential new "genetic chemotherapy" approach to cancer treatment that could significantly reduce side effects and the development of treatment resistance compared with traditional chemotherapy.

18 Apr 2013

Mindfulness-based cognitive therapies have significant benefits for veterans with PTSD

Mindfulness exercises that include meditation, stretching, and acceptance of thoughts and emotions might help veterans with combat-related post-traumatic stress disorder find relief from their symptoms.

18 Apr 2013

Hospitals profit when surgeries go wrong, study finds

The study, which was published Tuesday in The Journal of the American Medical Association, found that hospitals earned 330 percent higher profit margins on surgeries with one or more complications, because private insurers pay them for longer stays and extra care.

18 Apr 2013

Medical Condition News

ESCEO and IOF honor Dr. Mary L. Bouxsein with ESCEO-IOF Herbert Fleisch Medal

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

Telemedicine house calls for Parkinson’s patients: an interview with Dr Ray Dorsey, Johns Hopkins University

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Eli Lilly reports positive results from Phase III AWARD trials of type 2 diabetes drug, dulaglutide

Mast Therapeutics' data show that MST-188 reduces aggregation of both older and younger RBC

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

UTHealth neuroscientists demonstrate new strategy to overcome memory deficits

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

Study: Patients who suffer STEMI heart attacks while hospitalized are 10 times more likely to die

Americans with brain diseases have more difficulty in finding a neurologist, new study reveals

European Congress on Osteoporosis & Osteoarthritis starts in Rome

State roundup: Immigration proposal could mean big state health care costs

UTMB researchers identify protein that can interfere with the brain's response to leptin

Scorecard compares how countries within EU care for people with osteoporosis

More culturally relevant cancer prevention education needed for minority populations

New pre-clinical study suggests novel drug combination therapy for leukemia treatment

Researchers find potential new genetic chemotherapy approach for cancer treatment

Mindfulness-based cognitive therapies have significant benefits for veterans with PTSD

Hospitals profit when surgeries go wrong, study finds

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News